Guidelines for the management of hidradenitis suppurativa: recommendations supported by the Centre of Evidence of the French Society of Dermatology

Guidelines for the management of hidradenitis suppurativa: recommendations supported by the Centre of Evidence of the French Society of Dermatology

Hidradenitis suppurativa (HS) is a painful chronic inflammatory skin disease that impacts quality of life substantially. Its prevalence is estimated to be 0·7%. 1 Various pathophysiological hypotheses exist, but there is no therapeutic consensus, which complicates the management of patients with HS.

Therefore, the Centre of Evidence of the French Society of Dermatology initiated a standardized recommendation process for HS.


Read full Guideline